Eargo 6 vs Resound Vivia 9 60S microRIE

The Eargo 6 is a premium-priced OTC hearing aid ($2,250) that earned a B grade and a SoundScore of 3.4/5 in our lab testing, placing it in the top 63% of OTC hearing aids we've evaluated. This invisible-in-ear device delivers solid speech clarity in quiet environments, scoring 3.3/5—notably 0.53 points above the OTC category average. Own-voice comfort is also above average at 2.9/5, though mixed in absolute terms. However, the Eargo 6 shows significant weaknesses in challenging listening situations, with speech-in-noise performance scoring just 1.0/5, falling 0.48 points below the category average. The most notable limitation is music streaming, which scored 0.0/5 in our testing—substantially below the category average. Feedback handling scored 3.3/5, solid in absolute terms but 1.24 points below the OTC average of 4.54/5. The device uses rechargeable batteries and maintains a fully invisible profile when worn. The Eargo 6 may suit consumers who prioritize discreet aesthetics and primarily need help hearing conversations in quieter settings. However, shoppers should note that alternatives like the Sony CRE-C10 and Olive Union Air achieved higher SoundScores at lower price points. Those frequently in noisy environments or who value music streaming should explore other options.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.